EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study

Irfan Yasin iD, Anna Stengel, Haipeng Shao, Amandeep Kaur, Emily F Mason, Pranav P Patwardhan iD, Nathanael G Bailey, Sharmila Ghosh, Kedar V Inamdar, Anand A Patel, Madhavi Pandiri, Jingjing Zhang und 16 weitere

Cancer · 2026

DOI: 10.1002/cncr.70210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2026. Verfasst von Irfan Yasin und 27 weiteren Autor:innen. Beteiligte Einrichtung: Pathology (Hematology/Oncology & Hematopathology & Genomic Pathology & Cytogenetics), Medicine (Hematology/Oncology), The University of Chicago Medic…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Chromosomes, Human, Pair 5, Chromosome Aberrations, Myelodysplastic Syndromes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Isolated chromosome 5/5q losses (–5/5q) without TP53 mutations are associated with favorable outcomes in myeloid neoplasms (MN) with

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Chromosomes, Human, Pair 5Chromosome AberrationsMyelodysplastic SyndromesHumansFemaleMaleMiddle AgedAgedMutationPrognosisAdultHematopoietic Stem Cell TransplantationAged, 80 and over

Stichwörter der Autor:innen

AMLMDSTP53cytogeneticsoutcomespathology

Substanzen

Tumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • Pathology (Hematology/Oncology & Hematopathology & Genomic Pathology & Cytogenetics), Medicine (Hematology/Oncology), The University of Chicago Medicine, Chicago, Illinois, USA.
  • Munich Leukemia Laboratory, Munich, Germany.
  • Pathology (Hematopathology), Medicine (Hematology Oncology), H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Pathology (Molecular Pathology), Endeavor Health Northshore Hospital, Evanston, Illinois, USA.
  • Pathology, Microbiology, and Immunology (Hematopathology), Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Pathology (Hematopathology), University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Irfan Yasin, Pranav P Patwardhan, Ayalew Tefferi, Talha Badar, Girish Venkataraman

Zitieren

APA

Yasin, I., Stengel, A., Shao, H., Kaur, A., Mason, E. F., Patwardhan, P. P., Bailey, N. G., Ghosh, S., Inamdar, K. V., Patel, A. A., Pandiri, M., Zhang, J., Sojitra, P., Tariq, H., Pan, Z., Wiredja, D., Wang, P., Tjota, M. Y., Segal, J. P., …, & Venkataraman, G. (2026). Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study. Cancer. https://doi.org/10.1002/cncr.70210

Vancouver

Yasin I, Stengel A, Shao H, Kaur A, Mason EF, Patwardhan PP, et al. Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study. Cancer. 2026. doi:10.1002/cncr.70210

BibTeX
@article{Yasin2026,
  author = {Yasin, Irfan and Stengel, Anna and Shao, Haipeng and Kaur, Amandeep and Mason, Emily F and Patwardhan, Pranav P and Bailey, Nathanael G and Ghosh, Sharmila and Inamdar, Kedar V and Patel, Anand A and Pandiri, Madhavi and Zhang, Jingjing and Sojitra, Payal and Tariq, Hamza and Pan, Zenggang and Wiredja, Danica and Wang, Peng and Tjota, Melissa Y and Segal, Jeremy P and Chang, Hong and Sallman, David A and Arber, Daniel A and Tefferi, Ayalew and Badar, Talha and Perry, Anamarija M and Haferlach, Claudia and Lager, Angela M and Venkataraman, Girish},
  title = {Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study},
  journal = {Cancer},
  year = {2026},
  doi = {10.1002/cncr.70210}
}
Kostenlos starten →